Chest x-rays using a deep learning-based model.
Eisai executive who helped lead development of Alzheimer’s drug to retire
Japanese drugmaker Eisai said Tuesday that Ivan Cheung, chairman of its U.S. operations and global head of its Alzheimer’s disease unit, will retire at the